Share on StockTwits
 

Victrex (LON:VCT)‘s stock had its “hold” rating reiterated by equities research analysts at N+1 Singer in a research note issued to investors on Tuesday, AnalystRatings.Net reports. They currently have a GBX 1,645 ($26.39) price objective on the stock. N+1 Singer’s price objective suggests a potential upside of 5.18% from the company’s current price.

Victrex (LON:VCT) opened at 1590.00 on Tuesday. Victrex has a one year low of GBX 1364.00 and a one year high of GBX 1791.00. The stock’s 50-day moving average is GBX 1593. and its 200-day moving average is GBX 1609.. The company’s market cap is £1.339 billion.

VCT has been the subject of a number of other recent research reports. Analysts at Jefferies Group reiterated a “hold” rating on shares of Victrex in a research note to investors on Tuesday. They now have a GBX 1,760 ($28.24) price target on the stock. Separately, analysts at Barclays Capital reiterated an “overweight” rating on shares of Victrex in a research note to investors on Thursday, October 3rd. They now have a GBX 1,860 ($29.84) price target on the stock. Finally, analysts at Bank of America Corp. reiterated an “underperform” rating on shares of Victrex in a research note to investors on Monday, September 30th. They now have a GBX 1,400 ($22.46) price target on the stock. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of GBX 1,661.54 ($26.66).

Victrex plc is engaged in the manufacturing and selling of high performance polymers. The Company’s business is organized as two business units: Victrex Polymer Solutions (LON:VCT) and Invibio Biomaterial Solutions (Invibio).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.